Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Saksela, K.
space
  arrow  Baltimore, D.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

HIV-1 Messenger RNA in Peripheral Blood Mononuclear Cells as an Early Marker of Risk for Progression to AIDS

right arrow Kalle Saksela, MD, PhD; Cladd E. Stevens, MD; Pablo Rubinstein, MD; Patricia E. Taylor, PhD; and David Baltimore, PhD

1 November 1995 | Volume 123 Issue 9 | Pages 641-648

Objective: To establish human immunodeficiency virus type 1 (HIV-1) messenger RNA (mRNA) expression in peripheral blood mononuclear cells as a marker of risk for progression to the acquired immunodeficiency syndrome (AIDS) in a large cohort of HIV-infected persons followed for a prolonged period.

Design: Retrospective testing of cryopreserved, coded specimens.

Setting: Research laboratories at the New York Blood Center and the Rockefeller University.

Patients: 150 homosexual men infected with HIV-1 who did not have an AIDS diagnosis at the time of testing.

Measurements: Multiply spliced and unspliced HIV-1 mRNAs in total peripheral blood mononuclear cell RNA were quantitated using reverse transcriptase-initiated polymerase chain reaction (PCR) and compared with other laboratory data and clinical outcome during the subsequent 8 years.

Results: Although HIV-1 mRNA expression generally correlated with immunologic status, it was associated with future disease progression independently of CD4+ cell counts or their rate of decrease at the time of sampling. The association of HIV-1 mRNA with disease progression in persons with CD4+ cell counts higher than the median (> 624 cells/mm3) was particularly noteworthy; further variation in the CD4+ cell counts within this group was not prognostically significant.

Conclusions: The expression of HIV-1 mRNA in peripheral blood mononuclear cells is a strong independent marker for future HIV disease progression, even in persons with normal T-cell subsets.

Author and Article Information
space

From the Rockefeller University and the New York Blood Center, New York, New York; and the Massachusetts Institute of Technology, Cambridge, Massachusetts.
Grant Support: In part by grant A122346 from the National Institutes of Health (Dr. Baltimore) and the Aaron Diamond Foundation for AIDS research (Dr. Saksela).
Requests for Reprints: Kalle Saksela, MD, PhD, The Rockefeller University, Box 285, 1230 York Avenue, New York, NY 10021.
Current Author Addresses: Dr. Saksela: The Rockefeller University, Box 285, 1230 York Avenue, New York, NY 10021.


Related articles in Annals:

Editorials
Predicting Progression to AIDS
Warner C. Greene
Annals 1995 123: 726-727. [Full Text]  



This article has been cited by other articles:


Home page
J. Virol.Home page
L. G. Kostrikis, G. Touloumi, R. Karanicolas, N. Pantazis, C. Anastassopoulou, A. Karafoulidou, J. J. Goedert, and A. Hatzakis
Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load
J. Virol., September 11, 2002; 76(20): 10099 - 10108.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Zhu, D. Muthui, S. Holte, D. Nickle, F. Feng, S. Brodie, Y. Hwangbo, J. I. Mullins, and L. Corey
Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy
J. Virol., January 15, 2002; 76(2): 707 - 716.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. R. Lewin, M. Vesanen, L. Kostrikis, A. Hurley, M. Duran, L. Zhang, D. D. Ho, and M. Markowitz
Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy
J. Virol., July 1, 1999; 73(7): 6099 - 6103.
[Abstract] [Full Text]


Home page
J. Clin. Microbiol.Home page
R. Sun, J. Ku, H. Jayakar, J.-C. Kuo, D. Brambilla, S. Herman, M. Rosenstraus, and J. Spadoro
Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma
J. Clin. Microbiol., October 1, 1998; 36(10): 2964 - 2969.
[Abstract] [Full Text]


Home page
JOURNAL OF CORRECTIONAL HEALTH CAREHome page
A. M. Macher and E. P. Goosby
Primary HIV Infection/Acute Retroviral Syndrome: An Intervention Opportunity for Correctional Facilities
Journal of Correctional Health Care, April 1, 1998; 5(1): 51 - 62.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
Y.-W. Tang, G. W. Procop, and D. H. Persing
Molecular diagnostics of infectious diseases
Clin. Chem., November 1, 1997; 43(11): 2021 - 2038.
[Abstract] [Full Text] [PDF]


Home page
AIDS Clin CareHome page
HIV RNA and Prognosis
AIDS Clinical Care, January 1, 1996; 1996(101): 4 - 4.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1995 by the American College of Physicians.